8-K filing — LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)
Filed: 2026-11-05 AccNo: 0001005286-26-000049 Size: 152 KB Item 8.01: Other Events
Stocks · News reference
Lifecore Biomedical, Inc. announced that federal regulators have granted early termination of the Hart-Scott-Rodino (HSR) Act waiting period, marking a key step in its proposed merger.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Filed: 2026-11-05 AccNo: 0001005286-26-000049 Size: 152 KB Item 8.01: Other Events
Lifecore Biomedical, Inc. announced its financial results for the third quarter and nine months ended September 30, 2026, and provided a corporate update.
Lifecore Biomedical (NASDAQ:LFCR) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For comprehensive financial data
Major M&A deals include Valley National buys Bluevine, Roland Foods buys Savor Brands, Bloomberg completes Canoe deal.